Respiratory drugs specialist Vectura Group Plc (VEC.L) appointed AstraZeneca (AZN.L) executive James Ward-Lilley as chief executive officer effective Oct. 1.
Ward-Lilley replaces Chris Blackwell, who will leave the company at the end of this month.
02:12 Hotly Anticipated Google Fiber High-Speed Service Put on Hold as CEO Leaves53
22:46 8 takeaways from Apple’s Q4 2016 earnings call13
21:11 AT&T defends Time Warner merger, announces $35 DirecTV streaming15
10:57 CMO Today: AT&T’s Ambitious Advertising Plans With Time Warner Deal32